Nav: Home

When push comes to shove: Airway cells propel liver cancer spread to lungs

June 01, 2018

Kanazawa, Japan - Hepatocellular carcinoma (HCC) is the most common form of liver cancer, and the third biggest cause of death from cancer worldwide. Although HCC patients have benefited from recent improvements in diagnoses and various therapies, their average survival time is still only 16.2 months, falling to just under 6 months in those whose cancer has spread to their lungs.

Lung metastasis occurs when tumor cells from the liver enter the bloodstream. This process involves a range of tumor-host cell interactions, but the exact details have not been known. Now, a Japanese team of researchers led by Kanazawa University has undertaken a detailed investigation of the role of two different scavenger white blood cells (macrophages) of the lung, and a myriad of molecules associated with inflammation in a mouse model of metastasis. The study was reported in the Journal of Immunology.

The animal model was produced by injecting a mouse HCC cell line into the veins of mice, which resulted in the growth of small metastatic lung nodules that resembled HCC lung metastasis in humans. By monitoring the metastasis, the team detected an accumulation of two types of macrophages in the lungs: interstitial macrophages (IMs) and alveolar macrophages (AMs).

"IMs derive from the circulation, and were already known to aid the survival and growth of lung tumors," study first author Takuto Nosaka says. "Conversely, AMs come from tissue lining the inside of air sacs (alveoli) in the lungs, and were only recently shown to be involved in metastasis. Their function in lung metastasis was unclear, but their observed increase in this model is the first evidence that they must play an important role."

Indeed, AMs around the mouse lung nodules produced more of the inflammatory lipid leukotriene B4 (LTB4) than IMs. LTB4 activates immune cells, and directly boosts the proliferation and invasiveness of both human and mouse cancer cells, including HCC cells. AMs were also shown to directly promote tumor cell growth at metastatic lung nodules through LTB4 secretion.

"We next focused on AM recruitment from the bloodstream into the lungs, and showed that this was controlled by IMs which express the signaling molecule CCL2," corresponding author Naofumi Mukaida explains. "The CCL2 receptor, CCR2, is expressed by AMs, and binding of the two molecules controls AM accumulation."

This AM-IM interaction contributes to the progression of lung metastasis through the production of LTB4, suggesting the potential for developing a novel treatment approach that targets these molecules.
-end-


Kanazawa University

Related Cancer Articles:

Radiotherapy for invasive breast cancer increases the risk of second primary lung cancer
East Asian female breast cancer patients receiving radiotherapy have a higher risk of developing second primary lung cancer.
Cancer genomics continued: Triple negative breast cancer and cancer immunotherapy
Continuing PLOS Medicine's special issue on cancer genomics, Christos Hatzis of Yale University, New Haven, Conn., USA and colleagues describe a new subtype of triple negative breast cancer that may be more amenable to treatment than other cases of this difficult-to-treat disease.
Metabolite that promotes cancer cell transformation and colorectal cancer spread identified
Osaka University researchers revealed that the metabolite D-2-hydroxyglurate (D-2HG) promotes epithelial-mesenchymal transition of colorectal cancer cells, leading them to develop features of lower adherence to neighboring cells, increased invasiveness, and greater likelihood of metastatic spread.
UH Cancer Center researcher finds new driver of an aggressive form of brain cancer
University of Hawai'i Cancer Center researchers have identified an essential driver of tumor cell invasion in glioblastoma, the most aggressive form of brain cancer that can occur at any age.
UH Cancer Center researchers develop algorithm to find precise cancer treatments
University of Hawai'i Cancer Center researchers developed a computational algorithm to analyze 'Big Data' obtained from tumor samples to better understand and treat cancer.
More Cancer News and Cancer Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Teaching For Better Humans
More than test scores or good grades — what do kids need to prepare them for the future? This hour, guest host Manoush Zomorodi and TED speakers explore how to help children grow into better humans, in and out of the classroom. Guests include educators Olympia Della Flora and Liz Kleinrock, psychologist Thomas Curran, and writer Jacqueline Woodson.
Now Playing: Science for the People

#535 Superior
Apologies for the delay getting this week's episode out! A technical glitch slowed us down, but all is once again well. This week, we look at the often troubling intertwining of science and race: its long history, its ability to persist even during periods of disrepute, and the current forms it takes as it resurfaces, leveraging the internet and nationalism to buoy itself. We speak with Angela Saini, independent journalist and author of the new book "Superior: The Return of Race Science", about where race science went and how it's coming back.